PF-04620110
Talacotuzumab
Nesvacumab
Gatralimab
Enoblituzumab
Belatacept
Peldesine
Forigerimod
Icilin
Z-Asp-CH2-DCB
Tarlatamab
Thymopentin
LTV-1
Psora-4
glatiramer acetate
Lenalidomide-d5
BMS-1166-N-piperidine-COOH
BDC2,5 mimotope 1040-31
BDC2,5 mimotope 1040-31 TFA
Ivuxolimab
Goserelin
Anagrelide HCl
HDAC-IN-27
Rivaroxaban
CB2 receptor agonist 3
PROTAC BRD4 Degrader-1
PBP10
Sialyl-Lewis X
RIPK2-IN-1
Broussonin A
Broussonol E
Capecitabine-d11
CFI-400437
Gemfibrozil
Flurofamide
Monensin sodium salt
Azomycin
Chlorhexidine digluconate
Soyasaponin Ab
Sulfamethizole
Moroxydine HCl
Probucol
Fmoc-leucine-d10
Oleoylethanolamide
PPAR agonist 1
LJ570
Indotecan
BWX 46
Kinetensin(human)
BAM(8-22)
Namitecan
Topoisomerase II inhibitor 10
(Rac)-RP-6306
IRL-1038
Theobromine-d3
Preladenant
IMD 0354
Dihydrexidine hydrochloride
(+)-Valencene
GLP-1R modulator C5
